Ganirelix

Category: peptide

Aliases: Orgalutran, Antagon, Org-37462

Pharmacological Mechanism

Decapeptide GnRH-R antagonist engineered with D-arginine substitutions at positions 6 and 8 to reduce mast-cell histamine release compared with first-generation GnRH antagonists (Antide etc.). Used in IVF / ART controlled ovarian stimulation to block premature LH surge. Reaches suppression rapidly (hours) and effect wanes within 24 h of last dose — smoother endocrine control than agonist protocols.

Half-Life (t½)

SC: 12.8h

Dosing Guidelines

Target Organ Systems